top of page

A breakthrough in

GLAUCOMA IMPLANTS

Zero bleb complications
No Mitomycin C required
Superior efficacy
Highly cost effective

"The OptiShunt has tremendous potential to overcome the limitations of current glaucoma procedures. It may become one of the leading methods to manage glaucoma surgically 
in the future."

PROF. SANJAY ASRANI

DIRECTOR OF GLAUCOMA, DUKE EYE CENTRE, DUKE UNIVERSITY

RE-DEFINING

the treatment of

GLAUCOMA

Winner

Winner

Runner up

Finalist

Awards
Featured
bottom of page